Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Lost in transdifferentiation
Mark H. Hoofnagle, … , Brian R. Wamhoff, Gary K. Owens
Mark H. Hoofnagle, … , Brian R. Wamhoff, Gary K. Owens
Published May 1, 2004
Citation Information: J Clin Invest. 2004;113(9):1249-1251. https://doi.org/10.1172/JCI21761.
View: Text | PDF
Commentary

Lost in transdifferentiation

  • Text
  • PDF
Abstract

What are the true origins of the smooth muscle cells (SMCs) present in the intimal lesions of transplant arteriosclerosis? A new study in the JCI shows that Sca-1+ cells purified from the mouse aortic root can migrate through an irradiated vein graft to the neointima of the vessel and transdifferentiate to express the early SMC differentiation marker gene SM22. Do Sca-1+ cells transdifferentiate into SMC-like cells, or is activation of SMC marker genes a consequence of fusion of these cells with preexisting SMCs, a possibility raised by results of studies of adult stem cells in animal models of liver regeneration ? Or could this be bona fide transdifferentiation that recapitulates the pathologic processes in humans?

Authors

Mark H. Hoofnagle, Brian R. Wamhoff, Gary K. Owens

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
What are the true origins of the SMCs present in the intimal lesions of ...
What are the true origins of the SMCs present in the intimal lesions of TA? Hu et al. previously demonstrated that donor BMCs give rise to neointimal cells (I) and that a low percentage costained with smooth muscle α-actin, suggesting transdifferentiation of BMCs to SMCs. (II) However, when SM22-LacZ bone marrow was used for lineage tracing, the neointimal cells were SM22-LacZ negative, suggesting that the BMC-derived SM α-actin_positive intimal cells were some cell type other than smooth muscle (e.g., macrophages or myofibroblasts) or were not fully differentiated SMCs (III). Interestingly, cells from the host vessel (V) but not the donor vessel (IV) can give rise to intimal cells that are SM22-positive. However, it must be noted that the failure of donor vessel cells to contribute to the intima appears to be unique to this allograft model, wherein there is virtual destruction of all donor vessel cells, including medial SMCs. Thus, in this allograft model, a key question is, what is the source of the SM22-positive intimal cells derived from the host vessel? In this issue of the JCI, Hu et al. show that Sca-1+ cells purified from the adventitia of the aortic root (VI) can migrate through an irradiated vein graft to the neointima of the vessel and express SM22. These results are of interest in that they identify a potential new source of cells that contribute to neointimal formation in TA. However, several outstanding questions remain: Is this an artifact of exogenous application of the Sca-1+ cells? Does it represent fusion of these cells to SMCs? Or does this represent bona fide transdifferentiation of Sca-1+ cells from the adventitia into SMC lineages?

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts